Envestnet Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Envestnet Asset Management's PBYI Position: Q3 2026 in Review
Envestnet Asset Management reduced its Puma Biotechnology (PBYI) stake by 17% in Q3 2026, selling an estimated $43.6K and leaving 24,234 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #4664.
Envestnet Asset Management first reported a position in PBYI in Q1 2014 and has held it in 24 quarters since. The position peaked at $1.24M in Q1 2021. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Envestnet Asset Management held 24,234 shares of Puma Biotechnology worth $241K as of Q3 2026.
- Envestnet Asset Management sold 4,956 Puma Biotechnology shares in Q3 2026, an estimated $43.6K.
- Puma Biotechnology made up ﹤0.01% of Envestnet Asset Management's portfolio in Q3 2026, its #4664 holding.
- Envestnet Asset Management first reported a position in Puma Biotechnology in Q1 2014 and has held it in 24 quarters since.
- Envestnet Asset Management's Puma Biotechnology position peaked at $1.24M in Q1 2021.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Envestnet Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.